This inventor holds 2 USPTO granted patents. Top assignees: Scripps Research Institute, The University of Arizona. Active years: 1995-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-2000
Title: Wei Yuan: Innovator in Melanocortin Receptor Research
Introduction
Wei Yuan is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmacology, particularly in the development of melanocortin receptor antagonists and agonists. With a total of 2 patents, his work has the potential to impact various therapeutic areas.
Latest Patents
Wei Yuan's latest patents include innovative compounds that target melanocortin receptors. The first patent focuses on cyclic lactam peptides that inhibit the melanocortin 1 receptor (MC1R), melanocortin 3 receptor (MC3R), melanocortin 4 receptor (MC4R), and melanocortin 5 receptor (MC5R). The second patent discloses tight-binding inhibitors of leukotriene A4 hydrolase, detailing specific chemical structures and configurations that enhance their efficacy.
Career Highlights
Throughout his career, Wei Yuan has worked at prestigious institutions such as the Scripps Research Institute and the University of Arizona. His research has contributed to advancements in drug development and therapeutic strategies.
Collaborations
Wei Yuan has collaborated with notable colleagues, including Victor J Huby and Sejin Lim. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Wei Yuan's contributions to the field of pharmacology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile